3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Philadelphia Chromosome
2
Ovarian Neoplasms
2
Neoplasms
2
Recurrence
1
Peritoneal Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Leukemia
1
Genital Neoplasms, Female
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
fludarabine phosphate
2
Whole-Body Irradiation
2
Melphalan
2
Cyclophosphamide
2
Busulfan
2
asciminib
1
Tyrosine Kinase Inhibitors
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Rituximab
1
Pharmaceutical Preparations
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methotrexate
1
Etoposide
1
Cyclosporine
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
CT-P10
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic-Phase
×
nilotinib
×
30 days
×
Clear all
No trials found.